147 related articles for article (PubMed ID: 28558439)
1. Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity.
Nikuei P; Rajaei M; Malekzadeh K; Nejatizadeh A; Mohseni F; AtashAbParvar A
Iran Biomed J; 2017 Sep; 21(5):312-30. PubMed ID: 28558439
[TBL] [Abstract][Full Text] [Related]
2. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.
Perucci LO; Gomes KB; Freitas LG; Godoi LC; Alpoim PN; Pinheiro MB; Miranda AS; Teixeira AL; Dusse LM; Sousa LP
PLoS One; 2014; 9(5):e97632. PubMed ID: 24851923
[TBL] [Abstract][Full Text] [Related]
3. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
4. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
[TBL] [Abstract][Full Text] [Related]
5. Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt.
Nabiel Y; Mosbah A
Immunol Invest; 2019 Aug; 48(6):608-617. PubMed ID: 30794004
[No Abstract] [Full Text] [Related]
6. Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.
AbdelHalim RM; Ramadan DI; Zeyada R; Nasr AS; Mandour IA
Mol Diagn Ther; 2016 Apr; 20(2):135-49. PubMed ID: 26790664
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
8. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
9. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
10. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
[TBL] [Abstract][Full Text] [Related]
11. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
12. Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study.
Bell MJ; Roberts JM; Founds SA; Jeyabalan A; Terhorst L; Conley YP
BMC Pregnancy Childbirth; 2013 Apr; 13():82. PubMed ID: 23548068
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.
Sachan R; Patel ML; Dhiman S; Gupta P; Sachan P; Shyam R
Adv Biomed Res; 2016; 5():119. PubMed ID: 27563629
[TBL] [Abstract][Full Text] [Related]
14. Decidual mesenchymal stem/stromal cells from preeclamptic patients secrete endoglin, which at high levels inhibits endothelial cell attachment invitro.
Perera C; Zheng S; Kokkinos MI; Georgiou HM; Schoppet M; James PF; Brennecke SP; Kalionis B
Placenta; 2022 Aug; 126():175-183. PubMed ID: 35853410
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis values of serum STAT4 and sEng in preeclampsia.
Zhang L; Li X; Zhou C; You Z; Zhang J; Cao G
J Clin Lab Anal; 2020 Feb; 34(2):e23073. PubMed ID: 31628681
[TBL] [Abstract][Full Text] [Related]
16. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.
Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M
Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284
[TBL] [Abstract][Full Text] [Related]
17. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
18. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
19. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
20. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
